Virtus ETF Advisers LLC - Q2 2018 holdings

$113 Million is the total value of Virtus ETF Advisers LLC's 261 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 17.5% .

 Value Shares↓ Weighting
VPU SellVANGUARD WORLD FDSutilities etf$2,382,000
-6.7%
20,545
-10.1%
2.11%
-5.0%
RGNX SellREGENXBIO INC$1,040,000
+31.1%
14,492
-45.4%
0.92%
+33.6%
SRPT SellSAREPTA THERAPEUTICS INC$977,000
-19.7%
7,391
-55.0%
0.86%
-18.1%
CARA SellCARA THERAPEUTICS INC$927,000
+26.1%
48,423
-18.4%
0.82%
+28.5%
QURE SellUNIQURE NV$872,000
-12.7%
23,063
-45.7%
0.77%
-11.1%
FGEN SellFIBROGEN INC$860,000
+1.9%
13,732
-24.8%
0.76%
+3.8%
CBAY SellCYMABAY THERAPEUTICS INC$831,000
-31.4%
61,951
-33.6%
0.74%
-30.1%
MYOK SellMYOKARDIA INC$823,000
-14.0%
16,580
-15.4%
0.73%
-12.3%
BCRX SellBIOCRYST PHARMACEUTICALS$820,000
+11.6%
143,132
-7.1%
0.72%
+13.6%
MRTX SellMIRATI THERAPEUTICS INC$810,000
-38.8%
16,429
-61.9%
0.72%
-37.7%
VRTX SellVERTEX PHARMACEUTICALS INC$801,000
-22.4%
4,711
-25.6%
0.71%
-20.9%
REGN SellREGENERON PHARMACEUTICALS$798,000
-1.5%
2,313
-1.7%
0.71%
+0.4%
IMMU SellIMMUNOMEDICS INC$799,000
-9.4%
33,761
-44.1%
0.71%
-7.7%
BOLD SellAUDENTES THERAPEUTICS INC$795,000
+1.3%
20,810
-20.3%
0.70%
+3.2%
KURA SellKURA ONCOLOGY INC$794,000
-23.4%
43,633
-21.1%
0.70%
-22.0%
IOVA SellIOVANCE BIOTHERAPEUTICS INC$793,000
-48.4%
61,951
-31.9%
0.70%
-47.5%
AKCA SellAKCEA THERAPEUTICS INC$790,000
-21.6%
33,315
-15.3%
0.70%
-20.2%
GTHX SellG1 THERAPEUTICS INC$787,000
-44.3%
18,103
-52.5%
0.70%
-43.2%
LGND SellLIGAND PHARMACEUTICALS INC$787,000
-29.6%
3,800
-43.9%
0.70%
-28.2%
LOXO SellLOXO ONCOLOGY INC$787,000
-27.0%
4,535
-51.5%
0.70%
-25.6%
ONCE SellSPARK THERAPEUTICS INC$784,000
-41.2%
9,477
-52.7%
0.69%
-40.1%
GBT SellGLOBAL BLOOD THERAPEUTICS IN$780,000
-16.5%
17,249
-10.8%
0.69%
-14.8%
TGTX SellTG THERAPEUTICS INC$776,000
-39.2%
59,022
-34.4%
0.69%
-38.1%
FAS SellDIREXION SHS ETF TRdly fin bull new$776,000
-48.8%
12,324
-47.7%
0.69%
-47.8%
FOLD SellAMICUS THERAPEUTICS INC$772,000
-12.8%
49,455
-15.9%
0.68%
-11.1%
BMRN SellBIOMARIN PHARMACEUTICAL INC$764,000
-8.6%
8,114
-21.3%
0.68%
-6.9%
KPTI SellKARYOPHARM THERAPEUTICS INC$764,000
-30.0%
44,986
-44.7%
0.68%
-28.7%
LJPC SellLA JOLLA PHARMACEUTICAL CO$764,000
-17.7%
26,180
-16.0%
0.68%
-16.1%
ENTA SellENANTA PHARMACEUTICALS INC$762,000
-39.7%
6,577
-57.9%
0.67%
-38.5%
GILD SellGILEAD SCIENCES INC$761,000
-19.6%
10,744
-14.4%
0.67%
-18.0%
VNDA SellVANDA PHARMACEUTICALS INC$760,000
-29.6%
39,895
-37.7%
0.67%
-28.2%
ARRY SellARRAY BIOPHARMA INC$757,000
-32.5%
45,087
-34.4%
0.67%
-31.3%
MDGL SellMADRIGAL PHARMACEUTICALS INC$755,000
-32.9%
2,699
-72.0%
0.67%
-31.7%
IMGN SellIMMUNOGEN INC$753,000
-36.4%
77,365
-31.3%
0.67%
-35.2%
ICPT SellINTERCEPT PHARMACEUTICALS IN$753,000
-16.6%
8,970
-38.9%
0.67%
-14.9%
IRWD SellIRONWOOD PHARMACEUTICALS INC$751,000
-17.6%
39,291
-33.4%
0.66%
-15.9%
MGNX SellMACROGENICS INC$745,000
-24.6%
36,070
-8.1%
0.66%
-23.1%
SGEN SellSEATTLE GENETICS INC$740,000
-19.1%
11,148
-36.2%
0.65%
-17.6%
CTMX SellCYTOMX THERAPEUTICS INC$739,000
-25.5%
32,334
-7.3%
0.65%
-24.2%
STML SellSTEMLINE THERAPEUTICS INC$736,000
-7.0%
45,850
-11.3%
0.65%
-5.1%
VYGR SellVOYAGER THERAPEUTICS INC$733,000
-27.0%
37,502
-29.8%
0.65%
-25.6%
XNCR SellXENCOR INC$732,000
-31.3%
19,772
-44.4%
0.65%
-30.1%
MDCO SellMEDICINES CO$730,000
-33.4%
19,897
-40.2%
0.64%
-32.2%
UTHR SellUNITED THERAPEUTICS CORP DEL$723,000
-4.1%
6,394
-4.7%
0.64%
-2.3%
NBIX SellNEUROCRINE BIOSCIENCES INC$717,000
-33.0%
7,296
-43.4%
0.63%
-31.7%
RETA SellREATA PHARMACEUTICALS INCcl a$716,000
+16.0%
20,484
-31.9%
0.63%
+18.3%
RTRX SellRETROPHIN INC$714,000
-23.6%
26,176
-37.4%
0.63%
-22.2%
GERN SellGERON CORP$714,000
-55.7%
208,093
-45.2%
0.63%
-54.9%
PTCT SellPTC THERAPEUTICS INC$713,000
-43.9%
21,140
-54.9%
0.63%
-42.8%
CYTK SellCYTOKINETICS INC$713,000
+6.1%
85,880
-8.0%
0.63%
+8.1%
BGNE SellBEIGENE LTDsponsored adr$705,000
-48.1%
4,587
-43.2%
0.62%
-47.1%
DVAX SellDYNAVAX TECHNOLOGIES CORP$700,000
-26.4%
45,914
-4.1%
0.62%
-25.0%
RDUS SellRADIUS HEALTH INC$700,000
-37.2%
23,749
-23.4%
0.62%
-36.0%
EPZM SellEPIZYME INC$694,000
-34.1%
51,203
-13.7%
0.61%
-32.8%
BIIB SellBIOGEN INC$693,000
-10.5%
2,388
-15.5%
0.61%
-8.8%
TBPH SellTHERAVANCE BIOPHARMA INC$682,000
-14.8%
30,055
-8.9%
0.60%
-13.1%
LXRX SellLEXICON PHARMACEUTICALS INC$680,000
-11.7%
56,636
-37.0%
0.60%
-10.0%
RARE SellULTRAGENYX PHARMACEUTICAL IN$676,000
-21.9%
8,794
-48.2%
0.60%
-20.4%
ITCI SellINTRA CELLULAR THERAPIES INC$675,000
-36.0%
38,174
-23.8%
0.60%
-34.8%
OMER SellOMEROS CORP$673,000
+27.5%
37,076
-21.6%
0.60%
+29.9%
NVAX SellNOVAVAX INC$671,000
-43.4%
500,964
-11.3%
0.59%
-42.4%
ACOR SellACORDA THERAPEUTICS INC$665,000
-35.6%
23,175
-46.9%
0.59%
-34.3%
PTLA SellPORTOLA PHARMACEUTICALS INC$664,000
+5.9%
17,590
-8.4%
0.59%
+7.9%
MNTA SellMOMENTA PHARMACEUTICALS INC$649,000
-47.8%
31,740
-53.7%
0.57%
-46.8%
HALO SellHALOZYME THERAPEUTICS INC$648,000
-27.8%
38,423
-16.1%
0.57%
-26.4%
BLUE SellBLUEBIRD BIO INC$647,000
-8.7%
4,120
-0.8%
0.57%
-7.0%
AGIO SellAGIOS PHARMACEUTICALS INC$645,000
-45.2%
7,652
-46.9%
0.57%
-44.2%
IONS SellIONIS PHARMACEUTICALS INC$642,000
-17.2%
15,418
-12.3%
0.57%
-15.5%
NKTR SellNEKTAR THERAPEUTICS$632,000
-60.4%
12,942
-13.8%
0.56%
-59.6%
FTEC SellFIDELITYmsci info tech i$608,000
-81.1%
11,009
-82.2%
0.54%
-80.7%
KERX SellKERYX BIOPHARMACEUTICALS INC$544,000
-33.2%
144,564
-27.4%
0.48%
-31.9%
BABA SellALIBABA GROUP HLDG LTDsponsored ads$194,000
-8.5%
1,045
-9.4%
0.17%
-6.5%
HDB SellHDFC BANK LTD$149,000
-2.6%
1,417
-8.4%
0.13%
-0.8%
AMX SellAMERICA MOVIL SAB DE CV$105,000
-30.0%
6,308
-19.6%
0.09%
-28.5%
SQM SellSOCIEDAD QUIMICA MINERA DE Cspon adr ser b$84,000
-18.4%
1,743
-17.0%
0.07%
-16.9%
FMX SellFOMENTO ECONOMICO MEXICANO Sspon adr units$78,000
-25.0%
883
-22.1%
0.07%
-23.3%
JD SellJD COM INCspon adr cl a$61,000
-4.7%
1,566
-0.9%
0.05%
-3.6%
TV SellGRUPO TELEVISA SAspon adr rep ord$48,000
-9.4%
2,552
-22.4%
0.04%
-8.7%
HPQ SellHP INC$45,000
-2.2%
1,980
-5.8%
0.04%0.0%
NTES SellNETEASE INCsponsored adr$43,000
-15.7%
170
-7.1%
0.04%
-13.6%
NFLX SellNETFLIX INC$43,000
+22.9%
109
-6.8%
0.04%
+26.7%
IBN SellICICI BK LTDadr$35,000
-20.5%
4,338
-12.9%
0.03%
-18.4%
CX SellCEMEX SAB DE CVspon adr new$34,000
-22.7%
5,137
-23.5%
0.03%
-21.1%
PGR SellPROGRESSIVE CORP OHIO$33,000
-8.3%
553
-7.2%
0.03%
-6.5%
CI SellCIGNA CORPORATION$28,000
-17.6%
162
-20.2%
0.02%
-16.7%
ETFC SellE TRADE FINANCIAL CORP$26,000
-7.1%
430
-15.7%
0.02%
-4.2%
NTAP SellNETAPP INC$26,000
+18.2%
326
-10.4%
0.02%
+21.1%
TROW SellPRICE T ROWE GROUP INC$21,000
-22.2%
185
-25.4%
0.02%
-17.4%
INFY SellINFOSYS LTDsponsored adr$21,000
-16.0%
1,072
-24.3%
0.02%
-13.6%
KORS SellMICHAEL KORS HLDGS LTD$18,000
-5.3%
272
-12.8%
0.02%0.0%
CXO SellCONCHO RES INC$18,000
-18.2%
127
-11.8%
0.02%
-15.8%
CTXS SellCITRIX SYS INC$18,000
-10.0%
172
-18.9%
0.02%
-5.9%
AMTD SellTD AMERITRADE HLDG CORP$17,000
-22.7%
314
-15.6%
0.02%
-21.1%
ATHM SellAUTOHOME INCsp adr rp cl a$16,0000.0%154
-18.5%
0.01%0.0%
NEM SellNEWMONT MINING CORP$16,000
-27.3%
416
-26.8%
0.01%
-26.3%
MPC SellMARATHON PETE CORP$16,000
-15.8%
232
-12.5%
0.01%
-12.5%
WU SellWESTERN UN CO$13,000
-13.3%
633
-18.4%
0.01%
-15.4%
OMC SellOMNICOM GROUP INC$13,000
-38.1%
166
-42.0%
0.01%
-38.9%
SINA SellSINA CORPord$7,000
-36.4%
82
-21.9%
0.01%
-40.0%
HTHT ExitCHINA LODGING GROUP LTDsponsored adr$0-69
-100.0%
-0.01%
LBTYA ExitLIBERTY GLOBAL PLC$0-316
-100.0%
-0.01%
XRX ExitXEROX CORP$0-355
-100.0%
-0.01%
FCX ExitFREEPORT-MCMORAN INCcl b$0-694
-100.0%
-0.01%
PVH ExitPVH CORP$0-81
-100.0%
-0.01%
WMT ExitWAL-MART STORES INC$0-144
-100.0%
-0.01%
LNG ExitCHENIERE ENERGY INC$0-244
-100.0%
-0.01%
BKR ExitBAKER HUGHES A GE COcl a$0-465
-100.0%
-0.01%
DPZ ExitDOMINOS PIZZA INC$0-56
-100.0%
-0.01%
F ExitFORD MTR CO DEL$0-1,216
-100.0%
-0.01%
RF ExitREGIONS FINL CORP NEW$0-841
-100.0%
-0.01%
C ExitCITIGROUP INC$0-242
-100.0%
-0.01%
SCHW ExitSCHWAB CHARLES CORP NEW$0-532
-100.0%
-0.02%
AVGO ExitBROADCOM LTD$0-163
-100.0%
-0.03%
TTPH ExitTETRAPHASE PHARMACEUTICALS I$0-130,920
-100.0%
-0.35%
CALA ExitCALITHERA BIOSCIENCES INC$0-88,724
-100.0%
-0.48%
MCRB ExitSERES THERAPEUTICS INC$0-76,713
-100.0%
-0.49%
CLDX ExitCELLDEX THERAPEUTICS INC NEW$0-256,431
-100.0%
-0.52%
NLNK ExitNEWLINK GENETICS CORP$0-90,551
-100.0%
-0.57%
AVXS ExitAVEXIS INC$0-7,590
-100.0%
-0.81%
JNCE ExitJOUNCE THERAPEUTICS INC$0-58,867
-100.0%
-1.14%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-08-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VERTEX PHARMACEUTICALS INC31Q3 20231.7%
REGENERON PHARMACEUTICALS31Q3 20231.8%
INCYTE CORP31Q3 20232.1%
ENANTA PHARMACEUTICALS INC31Q3 20232.2%
EXELIXIS INC31Q3 20231.8%
VANDA PHARMACEUTICALS INC31Q3 20231.7%
IRONWOOD PHARMACEUTICALS INC31Q3 20232.0%
LIGAND PHARMACEUTICALS INC31Q3 20231.5%
GILEAD SCIENCES INC31Q3 20231.6%
HALOZYME THERAPEUTICS INC31Q3 20231.7%

View Virtus ETF Advisers LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-15
13F-HR2023-11-07
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Virtus ETF Advisers LLC's complete filings history.

Compare quarters

Export Virtus ETF Advisers LLC's holdings